Sleep Apnea During Pregnancy: Trimester-by-Trimester Risks and Safe Treatments
What changes month by month, why obstructive sleep apnea matters for both mother and baby, and how European obstetric care manages it safely from conception to postpartum.
Sleep apnea during pregnancy is increasingly recognised as a major contributor to maternal and fetal complications. Roughly 8 to 10 percent of pregnant women develop obstructive sleep apnea (OSA), with the highest prevalence in the third trimester. Hormonal swelling, weight gain, fluid retention, and rising progesterone all change the upper airway in ways that promote nighttime obstruction. For an overview of how the condition presents in women generally, see sleep apnea in women.
This guide walks through each trimester and the postpartum period. It explains the European Sleep Research Society and European Society of Hypertension positions, the safe treatment options across the EU, and how everyday devices including the Back2Sleep nasal stent fit alongside CPAP and mandibular advancement therapy. Learn more about how snoring affects relationships if it has changed your nighttime experience.
- OSA prevalence rises from 4 percent at conception to 15 to 20 percent in trimester 3.
- Untreated OSA raises preeclampsia risk roughly 2-fold.
- CPAP and oral appliances are safe across all trimesters.
- Most cases resolve within 6 months of delivery.
Why pregnancy changes the airway
The pregnant airway changes for four overlapping reasons. Each of them peaks at a different point in gestation, which is why the symptom curve climbs as the months progress.
Hormonal swelling
Estrogen and progesterone increase nasal mucosa engorgement starting in trimester 1. Up to 30 percent of pregnant women report rhinitis of pregnancy by week 16.
Weight gain
Average gain of 11 to 16 kilograms over a healthy pregnancy. Adipose deposits in the neck narrow the pharyngeal airway, especially in trimester 3.
Fluid shifts
Plasma volume rises 30 to 50 percent. Nighttime supine fluid redistribution from legs to neck triples the rostral fluid shift compared to non-pregnant women.
Diaphragm position
The growing uterus pushes the diaphragm upward. Functional residual capacity of the lungs drops 20 percent at term, reducing oxygen reserve during apneic events.

Trimester 1: weeks 1 to 13
Trimester 1 is when most pregnancy-related sleep changes start. About 30 to 40 percent of women report new daytime fatigue and 10 to 15 percent develop early rhinitis of pregnancy. Frank obstructive sleep apnea remains relatively uncommon at this stage but is more likely in women who already had snoring or risk factors before conception.
What changes
- Progesterone surge increases respiratory drive but also causes drowsiness.
- Estrogen induces nasal mucosa swelling and rhinitis.
- Tidal volume rises 30 to 40 percent.
- Sleep architecture shifts: more N1 and N2 sleep, slightly less REM.
Symptoms to watch
- New onset snoring within the first 8 weeks.
- Daytime sleepiness disproportionate to expected fatigue.
- Morning headaches.
- Witnessed pauses in breathing.
Safe interventions in trimester 1
| Action | Effect | European safety profile |
|---|---|---|
| Saline rinse twice daily | Reduces rhinitis of pregnancy by 30 to 40 percent | No restrictions |
| Side sleeping with pillow support | Reduces airway collapse and improves uterine blood flow | Recommended after week 12 |
| Avoid alcohol and sedatives | Removes respiratory depressants | Already standard pregnancy advice |
| Intranasal corticosteroid (mometasone, fluticasone) | Reduces nasal inflammation | EU pregnancy category B; OK with obstetric approval |
| Back2Sleep nasal stent | Mechanically opens nasal valve | CE-certified Class I; soft silicone, no medication |
Trimester 2: weeks 14 to 27
Trimester 2 brings rapid physiological adaptation. Roughly 8 to 12 percent of pregnant women now meet OSA criteria. Witnessed apneas, nighttime gasping, and unrefreshing sleep become more common. The European Society of Hypertension highlights this trimester as the optimal window for sleep apnea screening because preeclampsia and gestational diabetes diagnoses also begin to surface.
What changes
- Plasma volume increases by another 1.0 to 1.5 litres.
- Hemoglobin dilution causes physiological anemia.
- Diaphragm starts to elevate; functional residual capacity drops 10 percent.
- Average weight gain reaches 6 to 9 kg.
Screening recommendations
Most European obstetric units now use the Berlin questionnaire or the Pregnancy-Specific OSA Screen at the 20 to 24 week visit. Women with elevated blood pressure, BMI over 30, neck circumference over 38 cm, or any witnessed apnea are referred for polygraphy or polysomnography.
Treatment ladder in trimester 2
- Continue or refine trimester 1 measures (sleep position, saline rinses, nasal stent).
- Add mandibular advancement device for confirmed mild to moderate OSA.
- Initiate CPAP for moderate to severe OSA, with auto-titration to handle weight changes.
- Coordinate with obstetrician for blood pressure and glucose monitoring.

Trimester 3: weeks 28 to 40
Trimester 3 is the peak risk window. Up to 20 percent of women have OSA by week 36. The combination of fluid retention, weight gain, and reduced lung volume produces the strongest airway collapse. CPAP demand climbs, oral appliances may need refitting, and labour planning includes the OSA diagnosis.
What changes
- Total weight gain often reaches 11 to 16 kg.
- Functional residual capacity drops to 80 percent of baseline.
- Edema affects 50 to 70 percent of women, including the airway.
- Sleep fragmentation worsens because of frequent urination, fetal movement, reflux.
Why trimester 3 OSA matters most
- Highest preeclampsia risk window.
- Direct link to fetal growth restriction in severe OSA.
- Anesthesia planning for delivery is influenced by OSA severity.
- Postoperative recovery after caesarean section is harder if OSA is uncontrolled.
Treatment in trimester 3
| Treatment | OSA severity | European obstetric position |
|---|---|---|
| CPAP | Moderate to severe | First-line, safe throughout |
| Mandibular advancement device | Mild to moderate | Acceptable if comfortable |
| Positional therapy | Positional OSA | Side sleeping recommended after 28 weeks |
| Intranasal stent (Back2Sleep) | Snoring + mild OSA | Adjunct, CE-certified, no medication |
| Saline rinses + steroid spray | Adjunct | Continue from earlier trimesters |
Linked complications: preeclampsia and gestational diabetes
Sleep apnea overlaps strongly with two pregnancy complications. Treating OSA reduces both.
Preeclampsia connection
Recurrent oxygen drops trigger sympathetic surges, endothelial dysfunction, and rising blood pressure. The European Society of Hypertension 2024 update lists OSA as a contributing risk factor and recommends evaluation in pregnant women with new hypertension. Treating moderate to severe OSA with CPAP lowers blood pressure by 5 to 8 mmHg systolic.
Gestational diabetes connection
Repeated arousals raise cortisol, impair glucose tolerance, and worsen insulin resistance. Untreated OSA roughly triples gestational diabetes risk. Treatment improves fasting glucose within 4 to 6 weeks of CPAP initiation. For the wider perspective on metabolism and OSA, see sleep apnea and diet.
- If your blood pressure rises after week 20, ask about OSA screening.
- If your gestational diabetes is hard to control, ask about OSA screening.
- If your snoring increases sharply, ask about OSA screening.
Diagnosis pathway in EU obstetric care
European obstetric services rarely run dedicated sleep clinics. Most diagnoses involve coordinated referral.
- Midwife or obstetrician screen at routine antenatal visit.
- Risk-tier assessment using STOP-BANG or Berlin questionnaire.
- Home polygraphy as first test in many EU systems for cost and convenience.
- Polysomnography if home test is inconclusive or AHI close to 30.
- Sleep specialist consultation for treatment planning.
- Joint OB and sleep follow-up through to delivery.
Lifestyle measures across all trimesters
Beyond formal treatment, several lifestyle adjustments help across the entire pregnancy. Most are free, none have known harms, and the cumulative effect is meaningful.
Sleep position
European obstetric guidelines recommend left-side sleeping after week 28. Left side sleeping improves uterine blood flow, reduces vena cava compression, and reduces airway collapse. Use a long pregnancy pillow or wedge to maintain position.
Bedroom environment
- Keep bedroom temperature around 18 to 20 degrees Celsius.
- Run a humidifier in heated rooms during winter to prevent nasal dryness.
- Use mite-proof bedding if you have allergies.
- Elevate the head of the bed by 10 to 15 centimeters to reduce reflux and airway collapse.
Diet and hydration
- Avoid heavy meals within 3 hours of bedtime to reduce reflux.
- Stay hydrated throughout the day; thicker mucus blocks the airway more easily.
- Limit salt intake to reduce edema, which worsens airway tissue swelling.
- Avoid caffeine after midday to protect overall sleep quality.
Daily breathing practice
Slow nasal breathing exercises (4-second inhale, 6-second exhale) improve respiratory control and reduce sympathetic activation. Yoga and meditation lower overall stress, which reduces vasomotor reactivity and nasal congestion.
Coordinating obstetric and sleep care across the EU
Few countries have a dedicated obstetric sleep clinic. Most pregnant women navigate two separate teams: the obstetrician or midwife, and a sleep medicine specialist. Coordinated care matters because treatment decisions made in one clinic affect the other.
Information that should travel between teams
- Sleep study results and AHI on diagnosis.
- Treatment plan and adherence data (CPAP downloads, oral appliance worn-time).
- Blood pressure trend across antenatal visits.
- Glucose tolerance results from gestational diabetes screening.
- Plans for delivery, anaesthesia, and postnatal recovery.
Patient self-advocacy tips
- Request a digital copy of every sleep study report.
- Bring all reports to each obstetric and sleep visit.
- Ask the obstetrician to share BP and glucose trends with the sleep clinic.
- Ask the sleep clinic to share CPAP compliance reports with the obstetric team.
- Confirm the postnatal handover plan before delivery.
Postpartum: what happens after delivery
The postpartum period brings rapid physiological reversal. About 70 to 80 percent of pregnancy-related OSA resolves within 3 to 6 months. The remaining 20 to 30 percent reflects underlying OSA that pregnancy unmasked.
The first 6 weeks
- Hormones drop sharply within 24 to 72 hours of delivery.
- Plasma volume returns to baseline within 2 weeks.
- Adipose tissue redistribution takes 6 to 12 weeks.
- Sleep is fragmented by feeding schedules.
When to keep CPAP after delivery
- Pre-pregnancy BMI above 30.
- AHI above 15 on pregnancy sleep study.
- Persistent witnessed apneas at 6-week postnatal visit.
- Persistent hypertension or glucose dysregulation.
Follow-up sleep study
European obstetric and sleep guidelines recommend a follow-up polygraphy at 3 to 6 months postpartum. If AHI has fallen below 5 and symptoms have resolved, treatment can be paused with annual monitoring. If AHI remains above 5, ongoing OSA management continues as in non-pregnant adults.
Frequently asked questions
How common is sleep apnea during pregnancy?
Sleep apnea affects roughly 8 to 10 percent of pregnant women, rising to 15 to 20 percent in the third trimester. Hormonal swelling, weight gain, and fluid shifts narrow the upper airway. The European Sleep Research Society notes most cases are first detected during pregnancy and resolve after delivery.
What are the risks of untreated sleep apnea in pregnancy?
Untreated obstructive sleep apnea during pregnancy raises the risk of preeclampsia (2x), gestational diabetes (2 to 3x), preterm birth, and low birth weight. Both mother and baby benefit from screening and treatment, particularly in trimesters 2 and 3 when symptoms peak.
Is CPAP safe to use during pregnancy?
Yes. CPAP is the safest and most effective treatment for moderate to severe OSA in pregnancy. European obstetric guidelines support its use throughout all three trimesters. Pressures may need adjustment as the pregnancy progresses because of weight and fluid shifts.
Can I use a mandibular advancement device during pregnancy?
Yes, mandibular advancement devices (MAD) are considered safe in pregnancy for mild to moderate OSA. They are best fitted before conception or in the first trimester to allow comfortable wear as facial swelling progresses. Custom MADs from a qualified dentist remain the gold standard.
Are nasal stents safe to use while pregnant?
Soft silicone intranasal stents like Back2Sleep contain no medication and act mechanically inside the nostril. They are generally considered safe during pregnancy for snoring and mild OSA. As with any device, discuss your individual case with your obstetrician or midwife before starting.
When does pregnancy snoring become serious?
Snoring becomes a medical concern when accompanied by witnessed pauses, gasping awakenings, morning headaches, daytime sleepiness, or new-onset hypertension. The European Society of Hypertension recommends sleep apnea screening when blood pressure rises in pregnancy.
Will sleep apnea go away after the baby is born?
About 70 to 80 percent of pregnancy-related sleep apnea resolves within 3 to 6 months postpartum as weight normalises and hormones rebalance. The remaining 20 to 30 percent reflects an underlying chronic OSA that was unmasked by pregnancy and needs ongoing care.
This article is for general information only and does not replace medical advice. Consult a qualified healthcare professional in your country for diagnosis and personalised treatment of nasal disorders or sleep apnea.
What Back2Sleep Users Say
Ready for quieter nights? Discover the Back2Sleep starter kit and find the right fit for you.
Not sure if you are at risk? Take our sleep risk screening to find out in just a few minutes.
Want to learn how it works? Explore the Back2Sleep nasal stent designed for comfortable, effective relief.